Table 3.

Serotonin_1A ROI Analysis Results for Suicidal Ideation During Follow-up^a

Log-Transformed PB_F per ROI	3 mo			12 mo			24 mo
Log-Transformed PB_F per ROI	Estimate	P Value	Adjusted^b	Estimate	P Value	Adjusted^b	Estimate	P Value	Adjusted^b
RN	0.02	.001	NA	0.01	<.001	NA	−0.008	.21	NA

Amygdala	0.02	<.001	0.002	0.004	.26	0.26	−0.01	.03	0.29

Hippocampus	0.02	<.001	0.002	0.009	.03	0.03	−0.007	.18	0.29

Parahippocampal gyrus	0.01	.01	0.02	0.01	.004	0.02	−0.009	.10	0.29

Temporal lobe	0.01	.005	0.01	0.007	.02	0.03	−0.008	.11	0.29

Anterior cingulate gyrus	0.01	.02	0.02	0.009	.004	0.02	−0.008	.12	0.29

Dorsal PFC	0.01	.02	0.02	0.009	.01	0.02	−0.006	.24	0.29

Medial PFC	0.01	.01	0.02	0.008	.01	0.02	−0.005	.29	0.29

Orbital PFC	0.01	.02	0.02	0.007	.03	0.03	−0.006	.24	0.29

Insula	0.01	.006	0.01	0.009	.006	0.02	−0.005	.29	0.29

Occipital lobe	0.01	.01	0.02	0.008	.01	0.02	−0.006	.22	0.29

Parietal lobe	0.01	.02	0.02	0.008	.01	0.02	−0.007	.16	0.29

Abbreviations: BP_F, binding potential; NA, not applicable in the primary analysis; PFC, prefrontal cortex; RN, raphe nuclei; ROI, region of interest.

Patients underwent imaging with carbon 11-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile ([¹¹C]DASB).

Significance levels for exploratory analyses are adjusted using the Benjamini-Hochberg method.